January 25, 2021
Dr. O'Dwyer and Dr. Schnall

From the Co-Chairs, January 2021

The co-chairs look ahead to the new year, and acknowledge key successes from 2020—despite its many challenges
January 25, 2021
Doctor with male patient

Now Enrolling: EA8183 / ERADICATE for Patients with Localized Prostate Cancer

This phase III study, led by Dr. Alicia Morgans, is exploring a new treatment option for patients with prostate cancer with high-risk features
January 25, 2021
Woman patient speaking with doctor

Now Enrolling: EA2197 / OPT-IN for Gallbladder Cancer

This phase II/III study, led by Dr. Shishir Maithel, is assessing the role of neoadjuvant therapy for patients with incidental gallbladder cancer
January 25, 2021
Pink Rubik's cube

Joe Sparano: Refining Individual Risk in Breast Cancer

Dr. Sparano discusses the scientific and statistical collaboration behind a new tool, RSClin™, which integrates clinical–pathological and genomic risk information to guide adjuvant chemotherapy in node-negative breast cancer
January 25, 2021
PrECOG logo

Trial Spotlight: Jonathan Cohen, MD on Trial PrE0404 for Relapsed/Refractory Mantle Cell Lymphoma

This phase I/II study, led by Dr. Jonathon Cohen, is evaluating the combination of ibrutinib and the oral proteasome inhibitor ixazomib in patients with relapsed/refractory mantle cell lymphoma
January 25, 2021
News in Brief

News in Brief, January 2021